Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Somaiya Mayur Ian
Chief Financial Officer at NewAmsterdam Pharma Co N.V. Filing since 27 Jan 2025.
CIK 0001760303
Company
Date
Role
Action
Shares
Amount
Of holding
NAMS
NewAmsterdam Pharma Co N.V.
21 Jan 2026
Chief Financial Officer
Sold on a plan
39,784
$1.34M
40.5%
NAMS
NewAmsterdam Pharma Co N.V.
20 Jan 2026
Chief Financial Officer
Sold on a plan
60,216
$1.92M
50.8%
NAMS
NewAmsterdam Pharma Co N.V.
5 Jan 2026
Chief Financial Officer
Sold on a plan
5,118
$170.17K
13.5%
NAMS
NewAmsterdam Pharma Co N.V.
28 Jan 2025
Chief Financial Officer
Sold on a plan
14,900
no price
28.2%
NAMS
NewAmsterdam Pharma Co N.V.
27 Jan 2025
Chief Financial Officer
Sold on a plan
46,983
no price
55.3%
5 decisions on file.